Accessibility Menu
Emerging World Pharma logo

Emerging World Pharma(OTC) EWPI

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Emerging World Pharma last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-12
Emerging World Pharma stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-31
1 month+0%USD 0.002026-07-09
3 month-50%USD 0.002026-05-14
Year to date+0%USD 0.002025-12-30
1 year+0%USD 0.002025-08-07
3 year-99%USD 0.002023-07-27
5 year-99.89%USD 0.002021-08-12
Since inception-100%USD 1,562.502000-03-29

Emerging World Pharma Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

11.36 (High)

Price

$0.00

Volume

20

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

EWPI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Emerging World Pharma

Emerging World Pharma, Inc. focuses on pharmaceutical enterprises that produce generic medications in developing economies. The company provides essential manufacturing infrastructure and manages local personnel training while supplying necessary raw materials.

Products and Services
  • Manufacturing infrastructure for generic medication production
  • Training and skill-building for local personnel
  • Supply of essential raw components for pharmaceutical companies
Growth Outlook
  • Established in 1997, with a strong foundation in the pharmaceutical sector
  • Focus on partnerships with NGOs and government bodies enhances market reach
  • Investment strategy targets high-demand generic medication markets
Financial Highlights
  • Market capitalization of $11,930 indicates potential for growth
  • Stock price range between $0.000001 and $0.0001 shows significant volatility
  • Recent trading volume of 6 suggests low liquidity but potential interest
Emerging World Pharma, Inc. operates within the healthcare sector, specifically in drug manufacturing for specialty and generic medications. The company is strategically positioned to capitalize on the growing demand for affordable medications in developing regions. By focusing on partnerships with various organizations, Emerging World Pharma aims to expand its influence and operational capacity in the pharmaceutical market. The recent financial data indicates a market capitalization that reflects the company's potential for future growth, despite the current low trading volume.
AI Generated • Aug 29, 2026

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Sunyani, BA 20109, GH

EWPI Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

20

Avg. Volume

1.05K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Emerging World Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCAPBaron Capital Enterprise, Inc.
$0.00+0.00%
ALDAAtlantica, Inc.
$1.00+0.00%
HALLHallmark Financial Services, Inc.
$0.08-0.00%
IKTOiTokk, Inc
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About EWPI

What is the current price of Emerging World Pharma?

Emerging World Pharma is trading at $0.00 per share.

What is the 52-week range for Emerging World Pharma?

Over the past 52 weeks, Emerging World Pharma has traded between $0.00 and $0.00.

How much debt does Emerging World Pharma have?

Emerging World Pharma total debt is unavailable.

How much cash does Emerging World Pharma have on hand?

Emerging World Pharma does not have cash on hand data available.

What is Emerging World Pharma’s dividend yield?

Emerging World Pharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services